These results confirmed that frequent allelic losses of beclin 1 were part of reasons for beclin 1 down-regulation and mutations were unlikely the main regulatory mechanism for beclin 1 inactivation in breast cancer. The gene discussed is BECN1; the disease is breast carcinoma.